CollPlant Biotechnologies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Net Income	-7.02	-16.93	0.24	-5.77	-11.16	-6.25	-6.05	-7.75	-5.18
Depreciation & Amortization	1.1	1.08	0.77	0.66	0.54	0.34	0.23	0.24	0.22
Share-Based Compensation	1.94	2.17	1.6	1.67	1.13	1.43	0.96	0.99	1.13
Other Operating Activities	1.22	-0.02	-0.11	-1.01	3.8	3.26	-0.1	1.14	-0.2
Operating Cash Flow	-2.76	-13.7	2.5	-4.45	-5.7	-1.22	-4.97	-5.38	-4.03
Capital Expenditures	-0.89	-1.32	-1.56	-0.52	-1.46	-0.83	-0.13	-0.14	-0.39
Change in Investments	-0.27	30.24	-30	0	0	0	0	0	0
Investing Cash Flow	-1.16	28.92	-31.56	-0.52	-1.46	-0.83	-0.13	-0.14	-0.39
Share Issuance / Repurchase	1.11	1.87	38.76	4.49	5.45	2.78	9.18	5.14	2.79
Debt Issued / Paid	0	0	0	-0.02	-0.04	-0.02	-0.07	-0.01	0
Financing Cash Flow	1.11	1.87	38.76	4.47	5.41	2.75	9.11	5.14	2.79
Exchange Rate Effect	-0.38	-0.61	0.14	0.06	-0.06	-0.33	0.14	-0.04	0.03
Net Cash Flow	-3.19	16.49	9.85	-0.51	-1.75	0.7	4.01	-0.38	-1.63
Free Cash Flow	-3.65	-15.01	0.95	-4.97	-7.16	-2.05	-5.09	-5.52	-4.42
Free Cash Flow Margin	-33.30%	-5021.40%	6.04%	-80.98%	-309.06%	-40.87%	-1100.00%	-6797.60%	-
Free Cash Flow Per Share	-0.32	-1.36	0.10	-0.72	-1.44	-0.47	-1.91	-2.74	-2.61

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).